These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049 [TBL] [Abstract][Full Text] [Related]
15. Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection. Cohen E; Du D; Joyce D; Kapernick EA; Volovik Y; Kelly JW; Dillin A Aging Cell; 2010 Apr; 9(2):126-34. PubMed ID: 20003171 [TBL] [Abstract][Full Text] [Related]
16. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo. Bai Y; Ma X Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892 [TBL] [Abstract][Full Text] [Related]
18. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease. Paouri E; Tzara O; Zenelak S; Georgopoulos S J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177 [TBL] [Abstract][Full Text] [Related]